Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial). Issue 1 (February 2015)

• Record Type: Journal Article
• Authors: Lind, Marcus; Hirsch, Irl B.; Tuomilehto, Jaakko; Dahlqvist, Sofia; Torffvit, Ole; Pehrsson, Nils-Gunnar
• Is Part Of: Primary care diabetes. Volume 9:Issue 1(2015)
• Page Start: 15
• Page End: 22
• Publication Date: 2015-02
• Subjects: Diabetes -- Periodicals; 616.462
• DOI: 10.1016/j.pcd.2014.07.010
• Languages: English
• ISSNs: 1751-9918

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">The first study of its kind on incretin-based therapy together with MDI therapy.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">The majority of the studied patient group can be found in primary care settings.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Glycaemic variability will be evaluated by masked continuous glucose monitoring.</p> </list-item> </list> </p> </sec> </abstract>